Continuous Glucose and Ketone Monitoring for Adults with Type 1 Diabetes
GK5 CGKM
Other Study
Summary
Study start date: August 1, 2025
Actual date on which the first participant was enrolled.This study focuses on testing a new continuous glucose and ketone monitoring system designed for adults with type 1 diabetes. The goal is to check how accurately and safely this system can measure glucose and ketone levels compared to standard laboratory methods. The study aims to provide a more convenient way for individuals to monitor their glucose and ketone levels in real-time, potentially improving diabetes management and reducing the burden of daily monitoring. Participants in the study will use the new monitoring system to collect data on their glucose and ketone levels. During the study, they will have three visits to the clinical site, during which blood samples will be taken to compare with the readings from the new system. This involves taking blood from a vein and checking these results against the sensor's readings. The study will evaluate if the new system delivers accurate and reliable results, helping to ensure it is both safe and effective for regular use.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.12 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Henan University of Science and Technology
Luoyang, ChinaOpen Henan University of Science and Technology in Google Maps